Interaction of host and viral risk factors for development of cervical carcinoma in situ

被引:15
作者
Beskow, AH [1 ]
Engelmark, MT [1 ]
Magnusson, JJ [1 ]
Gyllensten, UB [1 ]
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden
关键词
cervical carcinoma; HLA; HPV; 16; E6;
D O I
10.1002/ijc.21212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infection by oncogenic human papillomavirus (HPV) is a necessary but not sufficient cause of cervical carcinoma. Several host genetic and viral factors have been reported to increase the risk of carcinoma development given an HPV infection. In our study, we have analysed the contribution of HPV 16 E6 sequence subtype and allelic variation at human leukocyte antigen (HLA) class II loci to the risk of developing cervical carcinoma in situ. Non-European-like HPV 16 E6 sequence subtypes were not found to be associated with an increased risk of cervical carcinoma, as compared to European-like variants. However, an association was found between the HPV 16 E6 L83V variant and the DR*04-DQ*03 haplotype. This association has been observed in several independent studies and shows that both the host HLA class II genotype and viral subtype will affect the risk of an infection progressing into cervical carcinoma. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:690 / 692
页数:3
相关论文
共 28 条
  • [1] HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY
    APPLE, RJ
    ERLICH, HA
    KLITZ, W
    MANOS, MM
    BECKER, TM
    WHEELER, CM
    [J]. NATURE GENETICS, 1994, 6 (02) : 157 - 162
  • [2] HLA class II alleles associated with infection by HPV16 in cervical cancer in situ
    Beskow, AH
    Josefsson, AM
    Gyllensten, UB
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (06) : 817 - 822
  • [3] Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO
  • [4] 2-X
  • [5] Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters
    Brady, CS
    Duggan-Keen, MF
    Davidson, JA
    Varley, JM
    Stern, PL
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 3233 - 3240
  • [6] Human papillomavirus type 16 variants and risk of cervical cancer
    Hildesheim, A
    Schiffman, M
    Bromley, C
    Wacholder, S
    Herrero, R
    Rodriguez, AC
    Bratti, MC
    Sherman, ME
    Scarpidis, U
    Lin, QQ
    Terai, M
    Bromley, RL
    Buetow, K
    Apple, RJ
    Burk, RD
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04): : 315 - 318
  • [7] Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay
    Josefsson, A
    Livak, K
    Gyllensten, U
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 490 - 496
  • [8] Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study
    Josefsson, AM
    Magnusson, PKE
    Ylitalo, N
    Sorensen, P
    Qwarforth-Tubbin, P
    Andersen, PK
    Melbye, M
    Adami, HO
    Gyllensten, UB
    [J]. LANCET, 2000, 355 (9222) : 2189 - 2193
  • [9] Londesborough P, 1996, INT J CANCER, V69, P364
  • [10] Genetic link to cervical tumours
    Magnusson, PKE
    Sparén, P
    Gyllensten, UB
    [J]. NATURE, 1999, 400 (6739) : 29 - 30